Sven Dethlefs, PhD
Sven Dethlefs, PhD
Chief Executive Officer
Sven Dethlefs, PhD, is a pharmaceutical leader with more than 25 years of experience and a track record in P&L leadership, R&D strategy, manufacturing, M&A, business transformation, capital markets, and board management. Prior to joining PureTech, Sven was the executive vice president and CEO of Teva North America where he led Teva’s businesses in the U.S. and Canada, including full P&L responsibility across pharma, biosimilars, and generics, with $8 billion in revenues.
“I have long believed in the potential of deupirfenidone and have followed its development, often firsthand, throughout my career. Leading Celea is an exciting opportunity to combine my institutional knowledge and strategic continuity behind the program with a uniquely qualified team to execute a pivotal Phase 3 trial.”